Open access
Open access
Powered by Google Translator Translator

Endocrinopathies from checkpoint inhibitors: incidence, outcomes, and management

12 May, 2023 | 13:36h | UTC

Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and management – Cleveland Clinic Journal of Medicine

Related:

Diagnostic criteria and management recommendations for immune related endocrinopathies following immune checkpoint inhibitor therapy for cancer – Endocrine Connections

Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society – Endocrinology and Metabolism

The Diagnosis and Management of Endocrine Side Effects of Immune Checkpoint Inhibitors – Deutsches Ärzteblatt International

Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports – Clinical Diabetes and Endocrinology

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.